Injecting Change and Convenience: Pioneering The Future of HIV/AIDS Care in Africa with Long-Acting Antiretrovirals

Authors

  • Patrick Ashinze University of Ilorin, Ilorin, Nigeria
  • Nelson Mafua Faculty of Clinical Sciences, Madonna University, Nigeria
  • Emmanuel Egbunu Federal Medical Centre, Bida, Nigeria
  • Mercy Abiodun-Oludoyi Iwosan Lagoon Hospital Worksite Clinic, Lagos, Nigeria
  • Sikiru Ademola Aremu Faculty of Clinical Sciences, University of Ilorin, Nigeria
  • Joyce Onyinyechukwu Ndubuisi Faculty of Clinical Sciences, Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Anambra, Nigeria
  • Chigozie Romanus Onwuasoeze Faculty of Clinical Sciences, Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Anambra, Nigeria
  • Deborah Aboyeji Faculty of Clinical Sciences, University of Ilorin, Ilorin, Nigeria

DOI:

https://doi.org/10.55320/mjz.52.1.625

Keywords:

HIV prevention, HIV infection, antiretroviral therapy (ART)

Abstract

Dear Editor,

We write to bring to attention, a critical matter in public health and infectious diseases research - the advent, implementation, and utilization of Long-ActingAntiretroviralTherapy(LA-ART)injectables, specifically Cabotegravir–Rilpivirine (CAB/RPV), in the context of Africa and the developing regions of the world by extension.

Downloads

Download data is not yet available.

Downloads

Published

03-02-2025

Issue

Vol. 52 No. 1 (2025)

Section

Letter to the Editor

License

Copyright (c) 2025 Medical Journal of Zambia

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Ashinze, P., Mafua, N., Egbunu, E. ., Abiodun-Oludoyi, M., Aremu, S. A. ., Ndubuisi, J. O., Onwuasoeze, C. R., & Aboyeji, D. (2025). Injecting Change and Convenience: Pioneering The Future of HIV/AIDS Care in Africa with Long-Acting Antiretrovirals. Medical Journal of Zambia, 52(1), 1-4. https://doi.org/10.55320/mjz.52.1.625

Most read articles by the same author(s)